Clinical Trial Update: Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating anlotinib hydrochloride capsules as maintenance therapy for intermediate-high risk pediatric rhabdomyosar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rhabdomyosarcoma Recurrent, Maintenance Treatment | Phase 2 | Status: NOT_YET_RECRUITING